COVID-19 Study Reveals Alarming Prevalence and Costs of Postoperative Acute Respiratory Distress Syndrome (ARDS)

Strategic Insights -

Research conducted in Spain between 2000 and 2022 has revealed a concerning prevalence of postoperative acute respiratory distress syndrome (ARDS) and its associated healthcare costs. The study, published in the Journal of Clinical Medicine, analyzed data from 93,192 ARDS patients, with 40,601 cases being postoperative ARDS. The postoperative ARDS prevalence varied between 0.05 and 0.22%, accounting for 45-50% of total ARDS cases during the study period.

Key Takeaways:

  • Postoperative acute respiratory distress syndrome (ARDS) is a recognized complication with reported prevalence rates of up to 20% and highly variable mortality.
  • The study found that postoperative ARDS prevalence varied between 0.05 and 0.22%, accounting for 45-50% of total ARDS cases recorded during the study period.
  • Hospital mortality was lower in postoperative ARDS compared with medical ARDS during the first phase (2000-2015) (47.0% vs. 49.9%).
  • The costs associated with postoperative ARDS remained significantly higher compared to medical ARDS.
  • The study aimed to evaluate the prevalence, hospital mortality, and healthcare costs of postoperative ARDS in Spain between 2000 and 2022 and to compare them with those of medical ARDS.
  • Funders for this research include Instituto de Salud Carlos III, Junta de Castilla y Leon, Consejeria de Educacion de Castilla y Leon, Fundacion Ramon Areces, ERAPerMed, The European Regional Development Funds, Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias, and Asociacion Cientifica Pulmon y Ventilacion Mecanica.

Statistics:

  • 93,192 ARDS patients were analyzed, with 40,601 cases being postoperative ARDS.
  • Postoperative ARDS prevalence varied between 0.05 and 0.22%.
  • Total ARDS cases recorded during the study period: 45-50%.
  • Hospital mortality in postoperative ARDS: 47.0% (vs. 49.9% for medical ARDS during the first phase).
  • Costs associated with postoperative ARDS: significantly higher compared to medical ARDS.

Sources:

  • Prevalence, Outcomes and Healthcare Costs of Postoperative ARDS Compared with Medical ARDS. Journal of Clinical Medicine, 2025;14(14):5125.
  • Journal of Clinical Medicine, St Alban-Anlage 66, Ch-4052 Basel, Switzerland.
  • Rocio Lopez-Herrero, BioCritic, Group for Biomedical Research in Critical Care Medicine, 47003 Valladolid, Spain.
  • Instituto de Salud Carlos III, Junta de Castilla y Leon, Consejeria de Educacion de Castilla y Leon, Fundacion Ramon Areces, ERAPerMed, The European Regional Development Funds, Fundacion Canaria Instituto de Investigacion Sanitaria de Canarias, and Asociacion Cientifica Pulmon y Ventilacion Mecanica.